Fast Results

Scores

Racecards

13:50 Lingfield

Friday 22 February 2019

All13:5014:2515:0015:3016:0516:40

Ladbrokes Handicap

Off time: 13:50 | Winning time: 59.02s

1^st

(4)

Pink Flamingo

39-3

6/4f

T: C & M JohnstonJ: J Fanning

Made all, pushed along over 1f out, ridden out final furlong

2^nd

(5)

Temple of Wonder

39-3

10/1

T: C WallisJ: L Morris

Chased leaders, pushed along 3f out, ridden and hung left over 1f out, ran on well on outside to take 2nd last strides

3^rd

(8)

Swiss Chime

38-10

14/1

T: D K IvoryJ: Megan Nicholls (5)

Always prominent, chased winner over 2f out, pushed along over 1f out, ridden and not quicken final furlong, lost 2nd last strides

4^th

nse

(2)

Kingi Compton

39-4

2/1

T: A WatsonJ: Edward Greatrex

Dwelt, in rear, pushed along and headway on inside over 1f out, ridden and kept on final furlong

5^th

(3)

Starchant

39-6

14/1

T: J J BridgerJ: K T O'Neill

Chased winner over 2f, pushed along well over 1f out, ridden and kept on same pace final furlong

6^th

(6)

Dandy Lad

39-4

5/1

T: R HughesJ: Finley Marsh (3)

Held up and behind, pushed along over 1f out, keeping on when not clear run well inside final furlong, no danger after

Unlimited Replays

of all UK and Irish races with our Race Replays

Discover Sporting Life Plus Benefits

Non-Runners

(7)

Axel Jacklin²⁸

Weight: 9-7| Age: 3

T: P Howling J: Joey Haynes

(1)

Solesmes¹⁸⁵

Weight: 9-1| Age: 3

T: A G Newcombe J: E J Walsh

Betting Breakdown

Tote Win:£1.90Pl:£1.30, £4.30EX:£9.40Tricast:£149.64SF:£17.12

Forecasts

Pink Flamingo (6/4), Kingi Compton (2/1), Dandy Lad (5/1), Axel Jacklin (5/1), Temple of Wonder (10/1), Swiss Chime (14/1), Starchant (14/1), Solesmes (16/1)

PINK FLAMINGO is getting ever nearer to gaining her maiden success and has first rate claims here especially with first-time blinkers a possible to find that little extra. Kingi Compton was highly impressive latest and rates the main threat despite a 6lb rise in weight for the success. Starchant could come on plenty for her recent reappearance and can't be ruled out now.